semaglutide 2mg side effects for diabetes and obesity treatment Comparative safety and side effects

To assess the realworld effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in ...

Join our private weight loss programme in Malvern & Worcester

Wondering whether GLP-1 is a lifelong commitment

Fibrosis, characterised by the excessive deposition of extracellular matrix via activated fibroblasts, is a pathological feature of several chronic inflammatory disorders, which collectively contribute significantly to global morbidity and mortality

Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity o...

Novo Nordisk and Eli Lilly each have a higher market capitalization than Tesla, a dramatic shift from the end of 2021, when Tesla was worth four times more than each of the weight loss kingpins.